Filing Details

Accession Number:
0001140361-18-044399
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-03 16:01:29
Reporting Period:
2018-11-21
Accepted Time:
2018-12-03 16:01:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1398733 Aquestive Therapeutics Inc. AQST Pharmaceutical Preparations (2834) 208623253
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1740092 W. Ken Marshall C/O Aquestive Therapeutics, Inc.
30 Technology Drive
Warren NJ 07059
Commercial Leader No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-21 1,445 $10.15 1,445 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. Shares held by the Tasro Consulting, LLC 401(k) Plan, Kenneth Marshall Trustee, f/b/o Kenneth Marshall.